Top 10 Stocks To Watch For 2019

“The Bet” (or how your money finds its way to Wall Street)

In this section, you will encounter, early on, the story of an investment bet I made nine years ago and, next, some strong opinions I have about investing. As a starter, though, I want to briefly describe Long Bets, a unique establishment that played a role in the bet.

Long Bets was seeded by Amazon (NASDAQ:AMZN)’s Jeff Bezos and operates as a non-profit organization that administers just what you’d guess: long-term bets. To participate, “proposers” post a proposition at Longbets.org that will be proved right or wrong at a distant date. They then wait for a contrary-minded party to take the other side of the bet. When a “doubter” steps forward, each side names a charity that will be the beneficiary if its side wins; parks its wager with Long Bets; and posts a short essay defending its position on the Long Bets website. When the bet is concluded, Long Bets pays off the winning charity.

Top 10 Stocks To Watch For 2019: 21Vianet Group, Inc.(VNET)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Blink Charging Co. (NASDAQ: BLNK) shares climbed 31.68 percent to close at $7.19 on Wednesday. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares gained 24.15 percent to close at $3.29. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    21Vianet Group, Inc. (NASDAQ: VNET) shares surged 24 percent to close at $6.82.
    Check-Cap Ltd. (NASDAQ: CHEK) gained 20.25 percent to close at $4.87.
    HUYA Inc. (NYSE: HUYA) shares surged 18.42 percent to close at $22.50
    Abaxis, Inc. (NASDAQ: ABAX) rose 16.15 percent to close at $83.34. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    Pain Therapeutics, Inc. (NASDAQ: PTIE) shares jumped 16.07 percent to close at $10.62.
    Bilibili Inc. (NASDAQ: BILI) rose 16.04 percent to close at $14.11.
    Gemphire Therapeutics Inc. (NASDAQ: GEMP) gained 14.88 percent to close at $6.33.
    Phoenix New Media Limited (NYSE: FENG) rose 13.96 percent to close at $5.55.
    Daqo New Energy Corp. (NYSE: DQ) jumped 13.88 percent to close at $67.27 on Wednesday.
    Sea Limited (NYSE: SE) jumped 12.59 percent to close at $11.98 after reporting Q1 results.
    Viking Therapeutics, Inc. (NASDAQ: VKTX) rose 12.01 percent to close at $5.13.
    Ascena Retail Group, Inc. (NASDAQ: ASNA) gained 11.93 percent to close at $3.19.
    Boot Barn Holdings, Inc. (NYSE: BOOT) climbed 11.66 percent to close at $24.52 on Wednesday after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Macy's, Inc. (NYSE: M) rose 10.83 percent to close at $33.17 after the company reported stronger-than-expected results for its first quarter and lifted guidance.
    ChemoCentryx, Inc. (NASDAQ: CCXI) gained 9.36 percent to close at $12.50. Canaccord Genuity initiated coverage on ChemoCentryx with a Buy rating.
    Biolinerx Ltd/S ADR (NASDAQ: BLRX)
  • [By Lisa Levin] Gainers
    Blink Charging Co. (NASDAQ: BLNK) shares jumped 26.5 percent to $6.9042. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares climbed 17.4 percent to $3.11. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    Flanigan's Enterprises, Inc. (NYSE: BDL) shares jumped 17 percent to $27.97 following Q2 results. Flanigan's Enterprises posted Q2 earnings of $0.75 per share on sales of $29.456 million.
    Borqs Technologies, Inc. (NASDAQ: BRQS) rose 15.8 percent to $8.05 after reporting Q1 results.
    Abaxis, Inc. (NASDAQ: ABAX) jumped 15.3 percent to $82.75. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    21Vianet Group, Inc. (NASDAQ: VNET) gained 15.1 percent to $6.33.
    Gemphire Therapeutics Inc. (NASDAQ: GEMP) rose 13.8 percent to $6.27.
    Enphase Energy, Inc. (NASDAQ: ENPH) gained 12.8 percent to $5.98. H.C. Wainwright initiated coverage on Enphase Energy with a Buy rating.
    PetIQ Inc (NASDAQ: PETQ) shares surged 12.1 percent to $21.68 after reporting a first-quarter sales beat.
    NF Energy Saving Corporation (NASDAQ: NFEC) climbed 11.6 percent to $2.399.
    Allied Healthcare Products, Inc. (NASDAQ: AHPI) surged 11.4 percent to $3.0643.
    Boot Barn Holdings, Inc. (NYSE: BOOT) gained 11.1 percent to $24.40 after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Ascena Retail Group, Inc. (NASDAQ: ASNA) rose 10.9 percent to $3.16.
    Sea Limited (NYSE: SE) gained 10.1 percent to $11.71 after reporting Q1 results.
    GEE Group, Inc. (NYSE: JOB) climbed 7.9 percent to $2.61 following Q2 results.
    The ONE Group Hospitality, Inc. (NASDAQ: STKS) gained 7.6 percent to $2.41 after reporting Q1 results.
    Biolinerx Ltd/S ADR (NASDAQ: BLRX) rose 7.3 percent to $0.8798 after the company was granted a patent approval. The clinical-st

Top 10 Stocks To Watch For 2019: Merit Medical Systems Inc.(MMSI)

Advisors’ Opinion:

  • [By Max Byerly]

    Eagle Boston Investment Management Inc. increased its stake in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 5.2% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 412,344 shares of the medical instruments supplier’s stock after buying an additional 20,334 shares during the quarter. Merit Medical Systems comprises approximately 1.9% of Eagle Boston Investment Management Inc.’s holdings, making the stock its 4th largest position. Eagle Boston Investment Management Inc. owned 0.82% of Merit Medical Systems worth $18,699,000 at the end of the most recent reporting period.

Top 10 Stocks To Watch For 2019: Pebblebrook Hotel Trust(PEB)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    Improving business travel demand during the first quarter drove Pebblebrook Hotel Trust (NYSE:PEB) to update its outlook earlier this month. Those travel trends turned out to be stronger than even its more optimistic expectations, helping the company to deliver results that were above the updated forecast. Because of that, the company is even more encouraged about what lies ahead in 2018.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Pebblebrook Hotel (PEB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    These are some of the news stories that may have effected Accern’s analysis:

    Get Pebblebrook Hotel alerts:

    Pebblebrook Hotel (PEB) Expected to Post Quarterly Sales of $206.07 Million (americanbankingnews.com) Keep Company Secrets Safe With a Strong Publishing Process (cmswire.com) Analysts Anticipate Pebblebrook Hotel (PEB) to Post $0.73 Earnings Per Share (americanbankingnews.com) Pebblebrook Hotel Forecasted to Earn Q2 2018 Earnings of $0.72 Per Share (PEB) (americanbankingnews.com)

    A number of brokerages recently issued reports on PEB. Boenning Scattergood restated a “hold” rating on shares of Pebblebrook Hotel in a report on Monday, April 30th. Zacks Investment Research upgraded Pebblebrook Hotel from a “hold” rating to a “strong-buy” rating and set a $40.00 target price on the stock in a report on Wednesday, May 2nd. Robert W. Baird lifted their target price on Pebblebrook Hotel from $37.00 to $38.00 and gave the stock a “hold” rating in a report on Tuesday, May 1st. Finally, ValuEngine cut Pebblebrook Hotel from a “strong-buy” rating to a “buy” rating in a report on Monday, April 2nd. Two analysts have rated the stock with a sell rating, three have assigned a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. Pebblebrook Hotel presently has an average rating of “Buy” and a consensus price target of $36.61.

Top 10 Stocks To Watch For 2019: CommunityOne Bancorp(COB)

Advisors’ Opinion:

  • [By Shane Hupp]

    Cobinhood (CURRENCY:COB) traded up 4.7% against the U.S. dollar during the 1 day period ending at 23:00 PM Eastern on May 16th. One Cobinhood token can currently be purchased for approximately $0.0862 or 0.00001024 BTC on exchanges including Mercatox, Cobinhood and EtherDelta (ForkDelta). During the last week, Cobinhood has traded 9.9% lower against the U.S. dollar. Cobinhood has a total market capitalization of $31.24 million and $16,592.00 worth of Cobinhood was traded on exchanges in the last day.

Top 10 Stocks To Watch For 2019: ENSERVCO Corporation(ENSV)

Advisors’ Opinion:

  • [By Logan Wallace]

    Enservco (NYSEAMERICAN:ENSV) will be issuing its quarterly earnings data before the market opens on Wednesday, May 9th.

    Enservco (NYSEAMERICAN:ENSV) last issued its earnings results on Thursday, March 22nd. The oil and gas producer reported ($0.04) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.01) by ($0.03). Enservco had a negative return on equity of 89.94% and a negative net margin of 43.71%. The business had revenue of $14.13 million during the quarter.

Top 10 Stocks To Watch For 2019: Syndax Pharmaceuticals, Inc. (SNDX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) was down, falling around 22 percent to $8.634 after the company issued updated results from Phase 2 ENCORE trial of entinostat in combo with KEYTRUDA.

  • [By ]

    Syndax (SNDX) is developing entinostat, a Class I HDAC inhibitor, for the treatment of solid tumors. Shares popped recently following the release of Syndax’s first quarter earnings results, but a bigger catalyst on the horizon is the upcoming ASCO oncology conference in June. Syndax is due to present updated data from the ENCORE-601 Phase 2 trial in melanoma and lung cancer.

  • [By Lisa Levin]

    Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) was down, falling around 21 percent to $8.76 after the company issued updated results from Phase 2 ENCORE trial of entinostat in combo with KEYTRUDA.

Top 10 Stocks To Watch For 2019: Petroleo Brasileiro S.A.- Petrobras(PBR)

Advisors’ Opinion:

  • [By Jayson Derrick]

    Improving oil prices mean a "major change" to the investment profile of Brazil-based Petroleo Brasil/ADR (NYSE: PBR), according to Bank of America Merrill Lynch.

  • [By Chris Lange]

    Short interest at Petroleo Brasileiro S.A. (NYSE: PBR), or Petrobras, increased to 34.35 million shares from the previous 31.85 million. The stock traded at $13.40 a share, in a 52-week range of $7.61 to $14.93. Unfortunately, Petrobras may be trading on an entirely different set of fundamentals and sentiment due to its ongoing woes in Brazil.

  • [By Chris Lange]

    Short interest at Petroleo Brasileiro S.A. (NYSE: PBR), or Petrobras, increased to 53.95 million shares from the previous 45.15 million. The stock traded at $12.65 a share, in a 52-week range of $7.61 to $13.99. Unfortunately, Petrobras may be trading on an entirely different set of fundamentals and sentiment due to its ongoing woes in Brazil.

Top 10 Stocks To Watch For 2019: ResMed Inc.(RMD)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    Stock No. 3: ResMed (NYSE:RMD). This is the company solving sleep apnea with its CPAP devices and this is a company that really innovated and brought that technology to the world. For people who are having trouble sleeping with clogged airways as they’re sleeping, ResMed is their best friend.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on ResMed (RMD)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Motley Fool Staff]

    Right now, it’s time for that yearly review of the ones he picked to honor the month, and also the briefly famous pregnant giraffe: five companies, and the first letters of their tickers spelled out A-P-R-I-L. They were Axon Enterprise(NASDAQ:AAXN), Grupo Aeroportuario del Pacific(NYSE:PAC), ResMed(NYSE:RMD), Intuitive Surgical (NASDAQ:ISRG), and Live Nation(NYSE:LYV).

Top 10 Stocks To Watch For 2019: CoreSite Realty Corporation(COR)

Advisors’ Opinion:

  • [By ]

    CoreSite Realty (COR) : “The data centers have been hot, but the REITS have not. I’m a buyer of this stock, not a seller.”

    Hi-Crush Partners (HCLP) : “This sector has gotten way too hot.”

  • [By ]

    In the Lightning Round, Cramer was bullish on Align Technology (ALGN) , Berkshire Hathaway (BRK.A)   (BRK.B) , Criticare Systems Inc.  (CMD) , Thermo Fisher Scientific (TMO) , IAC Interactive (IAC) and CoreSite Realty (COR) .

  • [By Jack Delaney]

    Take CoreSite Realty Corp. (NYSE: COR), for example. The stock price not only climbed 43.66% from 2017 to 2018, but it also pays its shareholders a dividend of $3.92 per share.

Top 10 Stocks To Watch For 2019: Gener8 Maritime, Inc.(GNRT)

Advisors’ Opinion:

  • [By Ethan Ryder]

    ILLEGAL ACTIVITY NOTICE: “General Maritime Co. (GNRT) Receives $8.50 Consensus Price Target from Analysts” was first published by Ticker Report and is owned by of Ticker Report. If you are accessing this piece on another site, it was illegally copied and republished in violation of international copyright and trademark laws. The correct version of this piece can be read at https://www.tickerreport.com/banking-finance/3361904/general-maritime-co-gnrt-receives-8-50-consensus-price-target-from-analysts.html.